Investment
Features
FeesSafety
Academy
More
Pluang+

Class action lawsuit targets Disc Medicine over alleged misleading FDA drug approval info.

Market News
23 Sep 2026
Newsfile Corp
View Source
Bearish
Class action lawsuit targets Disc Medicine over alleged misleading FDA drug approval info.

Rosen Law Firm is investigating a potential class action lawsuit against Disc Medicine after the FDA issued a Complete Response Letter rejecting the company's new drug application for bitopertin due to uncertainties. This FDA decision caused Disc Medicine's stock to drop 22% on February 13, 2026. Investors who purchased Disc Medicine securities may be eligible for compensation through this lawsuit, which is being prepared on a contingency fee basis. The law firm encourages affected investors to join the class action for potential recovery of losses without upfront costs.

The news about Rosen Law Firm's class action investigation into Disc Medicine provides context for readers interested in related health sector movements. For readers following the health sector, here is Pluang's market snapshot as of Sep 24, 2026 03:02 WIB: out of 100 priced US health stocks, 37 rose and 63 fell. Notable movers include AMLX at USD 30.74 with a -6.85% change and a typical hold time of 14 days, ASND at USD 221.34 down 6.83% with 90% buy order activity and a 55-day hold, and WGS at USD 84.87 down 6.53% with nearly balanced order activity and a 19-day hold.

More News

Costco reports strong Q4 sales growth ahead of full earnings release on Sept 24

Costco reports strong Q4 sales growth ahead of full earnings release on Sept 24

Costco Wholesale announced $93.9 billion in net sales for its fiscal Q4, up 11.3% from last year, with comparable sales rising 9.4%. The full earnings report on September 24 will reveal membership fees, total revenue, expenses, and profit details. An...

Company Fundamentals
Neutral
35 minutes ago
Jefferies maintains Buy rating on Life Time amid $6.5M insider stock sales by executive.

Jefferies maintains Buy rating on Life Time amid $6.5M insider stock sales by executive.

Jefferies reaffirmed its Buy rating on Life Time Group Holdings (LTH), citing a positive earnings outlook supported by a Zacks Rank of #2. The stock trades around $38.85 with a market cap near $8.68 billion. Despite this optimism, Executive Vice Pres...

Analyst Insights
Neutral
1 hour ago
GE Aerospace stock could rise 35% as analysts highlight strong backlog and new engine orders.

GE Aerospace stock could rise 35% as analysts highlight strong backlog and new engine orders.

Jefferies analysts set a new price target of $435 for General Electric Aerospace, implying a 35% upside from its current price of around $321. GE Aerospace's strong position is supported by a $170 billion commercial services backlog and 80,000 aircra...

Analyst Insights
Bullish
3 hours ago
Oracle expands Digital Assets Data Nexus to integrate digital money with traditional banking using AI and ISO 20022.

Oracle expands Digital Assets Data Nexus to integrate digital money with traditional banking using AI and ISO 20022.

Oracle announced enhancements to its Digital Assets Data Nexus platform, enabling banks to integrate digital money transactions with traditional payment systems using ISO 20022 messaging. The platform supports AI-enabled risk analysis, smart contract...

Market News
Bullish
4 hours ago
Csquare CEO to speak at RBC Capital Markets conference on Sept 30

Csquare CEO to speak at RBC Capital Markets conference on Sept 30

Csquare, a leading provider of carrier-neutral colocation data centers, announced that its CEO Spencer Mullee will speak at the RBC Capital Markets Global Communications Infrastructure Conference on September 30, 2026. The company operates a diverse ...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App